Health
Health
Health care coverage and access
S 3036 - 111Became Public Law No: 111-375.
Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.
Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.
Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.
Confidence is the strongest individual match score behind that sector.
Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.
Health
Health
Health care coverage and access
Secretary of Health and Human Data Sharing.--Agencies both within the Department of Health and Human Services and outside of the Department that have data relating to Alzheimer's shall share such data with the Secretary of Health and Human
ervices > Agencies both within the Department of Health and Human Services and outside of the Department that have data relating to Alzheimer’s shall share such data with the Secretary of Health and Human Services, or the Secretary's d
d Human nline">Agencies both within the Department of Health and Human Services and outside of the Department that have data relating to Alzheimer’s shall share such data with the Secretary of Health and Human Services, or the Secretary's d
Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.
CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.
LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.
CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.
Cost estimate for the bill as ordered reported by the Senate Committee on Health, Education, Labor, and Pensions on December 1, 2010
Cost estimate for the bill as ordered reported by the Senate Committee on Health, Education, Labor, and Pensions on December 1, 2010
Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.
Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.
They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.
If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.
Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.
Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.
LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.
A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.
Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.
(This measure has not been amended since it was passed by the Senate on December 8, 2010. The summary of that version is repeated here.) National Alzheimer's Project Act - (Sec. 2) Establishes in the Office of the Secretary of Health and Human Services (HHS) the National Alzheimer's Project. Requires the Secretary to: (1) be responsible for the creation and maintenance of an integrated national plan to overcome Alzheimer's; (2) provide information and coordination of Alzheimer's research and services across all federal agencies; (3) accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer's; (4) improve the early diagnosis of Alzheimer's disease and coordination of the care and treatment of citizens with Alzheimer's; (5) ensure the inclusion of ethnic and racial populations at higher risk for Alzheimer's, or least likely to receive care for Alzheimer's, in clinical, research, and service efforts with the purpose of decreasing health disparities in Alzheimer's; and (6) coordinate with international bodies to integrate and inform the fight against Alzheimer's globally. Directs the Secretary to:(1) use discretionary authority to evaluate all federal programs around Alzheimer's, including budget requests and approvals; and (2) annually assess the nation's progress in preparing for the escalating burden of Alzheimer's. Establishes an Advisory Council on Alzheimer's Research, Care, and Services to advise the Secretary and provide the Secretary and Congress with: (1) an initial evaluation of all federally -funded efforts in Alzheimer's research, clinical care, and institutional-, home-, and community-based programs and their outcomes; (2) initial recommendations for priority actions to expand, eliminate, coordinate, or condense programs based on their performance, mission, and purpose; (3) initial recommendations to improve health outcomes and reduce the financial impact of Alzheimer's on Medicare and other federally-funded programs and on families living with Alzheimer's disease; and (4) an annual evaluation of the implementation and outcomes of the recommendations through an updated national plan. Terminates the Advisory Council on December 31, 2025. Directs federal agencies to share Alzheimer's data with the Secretary. Sets forth reporting requirements. Terminates the Project on December 31, 2025.
(This measure has not been amended since it was passed by the Senate on December 8, 2010. The summary of that version is repeated here.) National Alzheimer's Project Act - (Sec. 2) Establishes in the Office of the Secretary of Health and Human Services (HHS) the National Alzheimer's Project. Requires the Secretary to: (1) be responsible for the creation and maintenance of an integrated national plan to overcome Alzheimer's; (2) provide information and coordination of Alzheimer's research and services across all federal agencies; (3) accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer's; (4) improve the early diagnosis of Alzheimer's disease and coordination of the care and treatment of citizens with Alzheimer's; (5) ensure the inclusion of ethnic and racial populations at higher risk for Alzheimer's, or least likely to receive care for Alzheimer's, in clinical, research, and service efforts with the purpose of decreasing health disparities in Alzheimer's; and (6) coordinate with international bodies to integrate and inform the fight against Alzheimer's globally. Directs the Secretary to: (1) use discretionary authority to evaluate all federal programs around Alzheimer's, including budget requests and approvals; and (2) annually assess the nation's progress in preparing for the escalating burden of Alzheimer's. Establishes an Advisory Council on Alzheimer's Research, Care, and Services to advise the Secretary and provide the Secretary and Congress with: (1) an initial evaluation of all federally funded efforts in Alzheimer's research, clinical care, and institutional-, home-, and community-based programs and their outcomes; (2) initial recommendations for priority actions to expand, eliminate, coordinate, or condense programs based on their performance, mission, and purpose; (3) initial recommendations to improve health outcomes and reduce the financial impact of Alzheimer's on Medicare and other federally-funded programs and on families living with Alzheimer's disease; and (4) an annual evaluation of the implementation and outcomes of the recommendations through an updated national plan. Terminates the Advisory Council on December 31, 2025. Directs federal agencies to share Alzheimer's data with the Secretary. Sets forth reporting requirements. Terminates the Project on December 31, 2025.
National Alzheimer's Project Act - (Sec. 2) Establishes in the Office of the Secretary of Health and Human Services (HHS) the National Alzheimer's Project. Requires the Secretary to: (1) be responsible for the creation and maintenance of an integrated national plan to overcome Alzheimer's; (2) provide information and coordination of Alzheimer's research and services across all federal agencies; (3) accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer's; (4) improve the early diagnosis of Alzheimer's disease and coordination of the care and treatment of citizens with Alzheimer's; (5) ensure the inclusion of ethnic and racial populations at higher risk for Alzheimer's, or least likely to receive care for Alzheimer's, in clinical, research, and service efforts with the purpose of decreasing health disparities in Alzheimer's; and (6) coordinate with international bodies to integrate and inform the fight against Alzheimer's globally. Directs the Secretary to: (1) use discretionary authority to evaluate all federal programs around Alzheimer's, including budget requests and approvals; and (2) annually assess the nation's progress in preparing for the escalating burden of Alzheimer's. Establishes an Advisory Council on Alzheimer's Research, Care, and Services to advise the Secretary and provide the Secretary and Congress with: (1) an initial evaluation of all federally funded efforts in Alzheimer's research, clinical care, and institutional-, home-, and community-based programs and their outcomes; (2) initial recommendations for priority actions to expand, eliminate, coordinate, or condense programs based on their performance, mission, and purpose; (3) initial recommendations to improve health outcomes and reduce the financial impact of Alzheimer's on Medicare and other federally-funded programs and on families living with Alzheimer's disease; and (4) an annual evaluation of the implementation and outcomes of the recommendations through an updated national plan. Terminates the Advisory Council on December 31, 2025. Directs federal agencies to share Alzheimer's data with the Secretary. Sets forth reporting requirements. Terminates the Project on December 31, 2025.
National Alzheimer's Project Act - Establishes in the Office of the Secretary of Health and Human Services (HHS) the Office of the National Alzheimer's Project to: (1) accelerate the development of treatments that would prevent, halt, or reverse the course of Alzheimer's; (2) create and maintain an integrated national plan to overcome Alzheimer's; (3) help to coordinate the health care and treatment of citizens with Alzheimer's; (4) ensure the inclusion of ethnic and racial populations that are at higher risk for Alzheimer's or that are least likely to receive care in clinical, research, and service efforts with the purpose of decreasing health disparities; (5) coordinate with international bodies to integrate and inform the fight against Alzheimer's globally; and (6) provide information and coordination of Alzheimer's research and services across all federal agencies. Sets forth the duties of the Director of the Office, including to use discretionary authority to evaluate all federal programs concerning Alzheimer's. Establishes in the Office an Advisory Council on Alzheimer's Research and Treatment.








Signed by President.
Signed by President.
Became Public Law No: 111-375.
Became Public Law No: 111-375.
Presented to President.
Presented to President.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H8369-8372)
DEBATE - The House proceeded with forty minutes of debate on S. 3036.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H8369)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8369)
Motion to reconsider laid on the table Agreed to without objection.
Cleared for White House.
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.(consideration: CR S8654-8655; text as passed Senate: CR S8654-8655)
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S8654-8655; text as passed Senate: CR S8654-8655)
Received in the House.
Message on Senate action sent to the House.
Held at the desk.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 675.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.